About the Journal

Synergy in Molecular Medicine (Synergy MM) is a peer-reviewed, open-access scientific journal dedicated to advancing research at the intersection of molecular biology and clinical medicine.
The journal publishes high-impact original research, critical reviews, and case-based reports that uncover the molecular foundations of human disease and their translation into innovative therapeutic strategies.
With a strong focus on precision and personalised medicine, Synergy MM fosters interdisciplinary collaboration and bridge the gap between bench-side discovery and bedside application.

Scope

Molecular Mechanisms of Disease

• Genetic and epigenetic regulation in pathogenesis
• Dysregulation of cellular signalling pathways
• Molecular underpinnings of inflammation, cancer, autoimmunity, and neurodegenerative disorders

Biomarkers and Diagnostics

• Identification and validation of diagnostic, prognostic, and predictive biomarkers
• Emerging techniques in liquid biopsy, multi-omics integration, and molecular imaging
• Development of high-throughput screening assays and diagnostic tools

Targeted Therapy and Drug Development

• Discovery and validation of molecular targets for therapeutic intervention
• Antibody-based treatments, small molecule drugs, and RNA-based therapeutics
• Pharmacogenomics and individualized treatment strategies
• Mechanisms of drug resistance and design of combination therapies

Clinical and Translational Research

• Clinical trials evaluating molecularly targeted agents
• Implementation of OMICs-driven strategies in real-world settings
• Patient stratification and precision therapeutic pathways
• Integration of artificial intelligence and machine learning in molecular medicine

Interdisciplinary and Societal Perspectives

• Ethical, legal, and societal considerations in personalized medicine
• Global health implications and equitable access to molecular diagnostics and therapies
• Education, capacity building, and training in molecular and translational sciences

Journal Salient Features

• Emphasis on translational relevance and direct clinical impact
• Promotion of integrative and multidisciplinary research combining molecular biology, pharmacology, and clinical sciences
• Support for emerging technologies, such as AI-driven diagnostics, RNA therapies, and nanomedicine
• Attention to real-world evidence and patient-centred approaches
• Consideration of ethical and policy implications, especially in global and underserved contexts
• Open Access model to ensure rapid, equitable, and global dissemination of research outputs

Target Audience

• Biomedical researchers and molecular biologists
• Clinicians and physician-scientists in precision and personalized medicine
• Biotechnologists and pharmaceutical scientists involved in drug discovery
• Health policymakers, ethicists, and educators in medical sciences
• Graduate students and postdoctoral fellows in translational medicine

 Article Types

• Original Research Articles: Basic, translational, or clinical studies with molecular relevance
• Review Articles: In-depth reviews on molecular pathways, biomarkers, technologies, and therapeutics
• Case Studies: Clinical cases illustrating diagnostic or therapeutic molecular approaches
• Short Communications: Brief but significant findings on novel molecular insights or methodologies
• Perspectives & Commentaries: Expert opinions on policy, ethics, emerging trends, or future directions

Publication Frequency

Synergy operates on an annual volume model, publishing articles online continuously upon acceptance. At the end of each calendar year, these articles are assembled into that year’s volume. Synergy MM will commence publication starting with Volume 2025.

Article Preparation

Please see the Author Guidelines to help ensure submissions align with the journal’s requirements. Accepted manuscripts will receive professional editorial review, formatting, and typesetting prior to publication

Article Processing Charges (APC)

Synergy Publishers will waive all publication fees for accepted articles until December 31, 2026. During this period, every accepted article will be published Open Access at no costs to authors.

Open Access Policy

Synergy Publishers is committed to the principles of open access. All published articles are freely available under the Creative Commons Attribution (CC BY 4.0) license. This ensures that published research can be shared, reused, and built upon without restriction, thus, maximizing the visibility and impact of the published work. For more information, please refer to our Open Access Policy.

Peer Review

Synergy journals maintain a single-blind peer review process, where reviewers remain anonymous, but authors’ identities are disclosed. This approach ensures impartiality while safeguarding the integrity, clarity, and originality of accepted manuscript. Further details are available in our Editorial Policy and Peer Review Policy.

Editorial Process

All submissions undergo a structured editorial workflow designed to guarantee fairness, transparency, and quality. Authors are encouraged to review  the journal’s editorial process before submission to understand how manuscripts are screened, reviewed, and advanced to publication. Further details are available in our Editorial Policy.

 Plagiarism Screening

At Synergy, originality is non-negotiable. All submissions are screened using iThenticate via Crossref Similarity Check. While the software identifies potential overlaps, final evaluation is always conducted manually by the editorial team to distinguish acceptable similarity from unethical duplication. Authors may be asked to revise their manuscripts based on similarity reports before the review process proceeds.

Publication Ethics

Synergy upholds the highest standards of publishing integrity. Guided by the Committee on Publication Ethics (COPE) principles, we maintain a strict zero-tolerance policy on plagiarism, data fabrication, falsification, or unethical authorship practices. Editors are trained to enforce these standards consistently, ensuring that all published work is original, accurate, and ethically sound. For more details, please see our Publication Ethics Policy.

Digital Archive

Synergy is committed to the long-term preservation and accessibility of scholarly research. All Synergy journals are archived in Portico, which provides secure and permanent digital archiving for scholarly publications.

Advertising Policy

Synergy journals currently do not host or promote commercial advertising. This policy protects editorial independence and scientific neutrality.

Direct Marketing

Synergy promotes its journals through academic engagement rather than commercial advertising. Awareness campaigns include distributing journal information through the website, brochures, and targeted invitations to conference speakers, workshop presenters, and seminar participants whose work aligns with the journal’s scope.